Epidemiology and treatment outcomes of diabetic retinopathy in a diabetic population from Cameroon

BMC Ophthalmology

Volumn 14, Issue 1, 2014, Pages

  Jingi, Ahmadou M ^a   Noubiap, Jean Jacques N ^b   Ellong, Augustin ^a   Bigna, Jean Joel R ^c   Mvogo, Côme Ebana ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Internal Medicine Unit Edea Regional Hospital   (Cameroon)

^c Goulfey District Hospital   (Cameroon)

Author keywords

Cameroon; Diabetes; Diabetic retinopathy; Photocoagulation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CAMEROON; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84897612632     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-14-19     Document Type: Article

References (23)

1. Projections of global mortality and burden of disease from 2002 to 2030. Mathers C, Loncar D, PLoS Med 2006 3 442 10.1371/journal.pmed.0030442 17132052
2. World Health Organization, The Global Burden of Disease: 2004 Update Geneva, Switzerland: WHO Press 2008
3. The Global Burden: diabetes and impaired glucose tolerance. Sicree R, Shaw J, Zimmet, Diabetes Atlas, IDF Brussels: International Diabetes Federation 4 2009
4. Prevalence of NIDDM and impaired glucose tolerance in rural and urban population in Cameroon. Mbanya JC, Ngongang J, Salah JN, Minkoulou E, Balkan B, Diabetologica 1997 40 824 826 10.1007/s001250050755
5. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. Mbanya JC, Solongwi E, J Cardiovasc Risk 2003 10 2 97 102 10.1097/00043798-200304000-00004 12668906
6. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). Sivaprasad S, Gupta B, Gulliford MC, Dodhia H, Mohamed M, Nagi D, Evans JR, PLoS One 2012 7 3 32182 10.1371/journal.pone.0032182 22412857
7. Microalbuminuria and retinopathy in a diabetic population in Cameroon. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB, Diabetes Res Clin Pract 1999 44 3 191 196 10.1016/S0168-8227(99)00052-2 10462142
8. Les Aspects cliniques De la Rétinopathie Diabétique à Yaoundé Moukouri EN, Nouedoui C, Mbanya JC, Médicine d'Afrique Noire 1995 42 424 428
9. Diabetic retinopathy. Bosco A, Leraria AC, Soriano D, Dos Santos RF, Massote P, Galvao D, Franco AC, Purish S, Ferreira AR, Arg Bras Endocrinol Metabol 2005 49 2 217 227
10. Visual prognosis in proliferating diabetic retinopathy. Beetham WP, Br J Ophthalmol 1963 47 611 619 10.1136/bjo.47.10.611 14188349
11. Rapport de présentation des résultats définitifs de 3ème recesement général de la population humaine. Bureau central des recensements et des études de population du Cameroun, Available on http://www.statistics-cameroon.org/downloads/Rapport-de- presentation-3-RGPH.pdf
12. Visual Standards-Aspects and Ranges of Vision Loss-Resolution adopted by the ICO, April 20, 2002. Available on www.icoph.org/pdf/visualstandardsreport. pdf
13. Diabetic retinopathy disease severity scale. American Academy of Ophtalmology, 2002 Available on one.aao.org/asset.axd?id=4b0447c9-24c6-411e- a888-3081553693d2
14. The prevalence of diabetic retinopathy among adults in the United States. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF, Arch Ophtalmol 2004 122 4 552 563
15. Prevalence and risk factors of diabetic retinopathy in children and young adults. Ben Hamouda H, Messaoud R, Grira S, Ayadi A, Khairallah M, Soua H, Sfar MT, J Fr Ophtalmol 2001 24 4 367 370 11351208
16. Prevalence and determinants of diabetic retinopathy and Cataracts in West African Type 2 diabetes patients. Rotimi C, Daniel H, Zhou J, Obisesan A, Chen G, Chen Y, Amoah A, Opoku V, Acheampong J, Agyenim-Boateng K, Eghan BA Jr, Oli J, Okafor G, Ofoegbu E, Osotimehin B, Abbiyesuku F, Johnson T, Fasanmade O, Doumatey A, Aje T, Collins F, Dunston G, et al. Ethn Dis 2003 13 2 110 S117 13677425
17. Epidemiological and angiofluorographic aspects of diabetic retinopathy in Senegal. De Madeiros-Quenun M, Ndiaye PA, Cisse A, Wane A, Diop SN, Ndoye-Roth PA, Ba EA, Ndiaye MR, Wade A, J Fr Ophtalmol 2005 26 2 160 163
18. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL, Arch Ophthalmol 1984 102 527 532 10.1001/archopht.1984.01040030405011 6367725
19. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Harris MI, Klein R, Welborn TA, Knuiman MW, Diabetes Care 1992 15 815 819 10.2337/diacare.15.7.815 1516497
20. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe non proliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial. PKC-DRS Study Group, Diabetes 2005 54 2188 2197 15983221
21. Diabetic retinopathy at the Yaoundé Central Hospital in Cameroon: epidemiology and angiographic findings. Nanfack N, Koki G, Mbuagbaw L, Bella AL, Pan Afr Med J 2012 13 54 23330045
22. Prevalence of retinopathy in non-insulin dependent diabetes mellitus at a diabetes Centre in Southern India. Rema M, Ponnaiya M, Mohan, Diabetes Res Clin Pract 1996 34 29 36 10.1016/S0168-8227(96)01327-7 8968688
23. Diabetic retinopathy in Oman: a hospital-based study. Khanderkar R, Al Lawatii AI, Mohamed AJ, Al Raisi A, Br J Ophthalmol 2003 87 1061 1064 10.1136/bjo.87.9.1061 12928265